Mineralys Therapeutics公布III期Launch-HTN试验亚组分析结果,证实Lorundrostat在高未满足医疗需求高血压患者中的疗效与安全性
Mineralys Therapeutics公布III期Launch-HTN试验亚组分析结果,证实Lorundrostat在高未满足医疗需求高血压患者中的疗效与安全性
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.